KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,187,008 | -22.0% | 18,848 | 0.0% | 0.01% | -21.4% |
| Q2 2023 | $4,087,189 | +31.1% | 18,848 | +9.8% | 0.01% | +27.3% |
| Q1 2023 | $3,118,577 | -7.6% | 17,169 | 0.0% | 0.01% | -15.4% |
| Q4 2022 | $3,373,709 | -12.6% | 17,169 | 0.0% | 0.01% | -18.8% |
| Q3 2022 | $3,862,000 | +40.5% | 17,169 | -21.0% | 0.02% | +60.0% |
| Q2 2022 | $2,749,000 | -7.3% | 21,733 | -7.1% | 0.01% | +11.1% |
| Q1 2022 | $2,965,000 | +6.7% | 23,389 | +10.3% | 0.01% | +12.5% |
| Q4 2021 | $2,779,000 | -12.7% | 21,210 | -18.5% | 0.01% | -20.0% |
| Q3 2021 | $3,183,000 | +27.4% | 26,016 | +18.7% | 0.01% | +25.0% |
| Q2 2021 | $2,498,000 | – | 21,917 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |